Moreover, Nrf2 luciferase analysis verified that Nrf2 binding to the ARE promoter was significantly increased in CyCl-treated colon cancer cells (Figure 5E), indicating the antioxidative actions of CyCl through activation of the Nrf2 signaling pathway. This evidence concerns the gene NFE2L2 and colonic neoplasm.